John Furey - Net Worth and Insider Trading
John Furey Net Worth
The estimated net worth of John Furey is at least $0 dollars as of 2024-09-20. John Furey is the COO of Spark Therapeutics Inc and owns about 0 shares of Spark Therapeutics Inc (ONCE) stock worth over $0. Details can be seen in John Furey's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that John Furey has not made any transactions after 2018-04-20 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of John Furey
John Furey Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, John Furey owns 2 companies in total, including Adaptimmune Therapeutics PLC (ADAP) , and Spark Therapeutics Inc (ONCE) .
Click here to see the complete history of John Furey’s form 4 insider trades.
Insider Ownership Summary of John Furey
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ADAP | Adaptimmune Therapeutics PLC | 2018-07-05 | director |
| ONCE | Spark Therapeutics Inc | 2018-04-20 | Chief Operating Officer |
John Furey Latest Holdings Summary
John Furey currently owns a total of 1 stock. John Furey owns 0 shares of Spark Therapeutics Inc (ONCE) as of April 20, 2018, with a value of $0.
Latest Holdings of John Furey
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ONCE | Spark Therapeutics Inc | 2018-04-20 | 0 | 113.57 | 0 |
Holding Weightings of John Furey
John Furey Form 4 Trading Tracker
According to the SEC Form 4 filings, John Furey has made a total of 0 transactions in Spark Therapeutics Inc (ONCE) over the past 5 years. The most-recent trade in Spark Therapeutics Inc is the sale of 6,723 shares on April 20, 2018, which brought John Furey around $554,648.
Insider Trading History of John Furey
- 1
John Furey Trading Performance
GuruFocus tracks the stock performance after each of John Furey's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by John Furey is -14.53%. GuruFocus also compares John Furey's trading performance to market benchmark return within the same time period. The performance of stocks bought by John Furey within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how John Furey's insider trading performs compared to the benchmark.
Performance of John Furey
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -31.04 | | | | | |
| Relative Return to S&P 500(%) | -34.67 | | | | | |
John Furey Ownership Network
John Furey Owned Company Details
What does Adaptimmune Therapeutics PLC do?
Who are the key executives at Adaptimmune Therapeutics PLC?
John Furey is the director of Adaptimmune Therapeutics PLC. Other key executives at Adaptimmune Therapeutics PLC include Chief Commercial Officer Cintia Piccina , Chief Medical Officer Elliot Norry , and Chief Operating Officer Bertrand William C Jr .
Adaptimmune Therapeutics PLC (ADAP) Insider Trades Summary
Over the past 18 months, John Furey made no insider transaction in Adaptimmune Therapeutics PLC (ADAP). Other recent insider transactions involving Adaptimmune Therapeutics PLC (ADAP) include a net sale of 73,322 shares made by Adrian Rawcliffe , a net sale of 35,120 shares made by John Lunger , and a net sale of 32,818 shares made by Bertrand William C Jr .
In summary, during the past 3 months, insiders sold 0 shares of Adaptimmune Therapeutics PLC (ADAP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 245,864 shares of Adaptimmune Therapeutics PLC (ADAP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 245,864 shares.
Adaptimmune Therapeutics PLC (ADAP)'s detailed insider trading history can be found in Insider Trading Tracker table.
Adaptimmune Therapeutics PLC Insider Transactions
John Furey Mailing Address
Above is the net worth, insider trading, and ownership report for John Furey. You might contact John Furey via mailing address: 3737 Market Street, Suite 1300, Philadelphia Pa 19104.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
